NANOTECH RCC Biomarkers
| Status: | Recruiting |
|---|---|
| Conditions: | Colorectal Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/6/2019 |
| Start Date: | August 2016 |
| End Date: | July 2020 |
| Contact: | Jeremiah Morrissey, PhD |
| Email: | morrissj@anest.wustl.edu |
| Phone: | (314) 454-7464 |
Nanotech Biomarkers For Renal Cancer Intervention: Clinical Validation & Utility
The incidence of renal cell carcinoma (RCC or kidney cancer) in men exceeds that of
pancreatic cancer or leukemia. In women, the incidence of RCC is similar to that of leukemia,
ovarian, or pancreatic cancer; thus, RCC is significant health issue. This study focuses on
identifying specific molecules [biomarkers] of RCC that can be used to develop a reliable
low-cost screening method at the point of service. If successful, our method would provide a
diagnostic test to distinguish benign kidney masses from malignant ones, eliminating the need
to surgically remove a kidney with a benign tumor.
pancreatic cancer or leukemia. In women, the incidence of RCC is similar to that of leukemia,
ovarian, or pancreatic cancer; thus, RCC is significant health issue. This study focuses on
identifying specific molecules [biomarkers] of RCC that can be used to develop a reliable
low-cost screening method at the point of service. If successful, our method would provide a
diagnostic test to distinguish benign kidney masses from malignant ones, eliminating the need
to surgically remove a kidney with a benign tumor.
Inclusion Criteria:
Patients 18 years of age and older undergoing surgery. Patient samples are divided into 2
groups based on their surgery: Patients with an imaged renal mass, encompassing about 300
patients/year (about 1200 total) of both malignant (about 80-85% of time) and benign (about
15-20% of time), and patients with non-kidney cancers, encompassing about 6,000
patients/year (about 24,000 total),
Exclusion Criteria:
Age <18 years and prisoners.
We found this trial at
1
site
Saint Louis, Missouri 63110
Phone: 314-747-1690
Click here to add this to my saved trials
